Phase III study of safety, tolerance, efficacy, pharmacokinetics, and costs of therapy with voriconazole or placebo in the prophylaxis of lung infiltrates in patients undergoing induction chemotherapy for acute myelogenous leukaemia.
Latest Information Update: 20 Feb 2012
At a glance
- Drugs Voriconazole (Primary)
- Indications Lung disorders
- Focus Therapeutic Use
- 20 Feb 2012 New trial record